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The von Hippel-Lindau (VHL) tumor suppressor functions as a ubiquitin ligase that mediates proteolytic inactivation of
hydroxylated a subunits of hypoxia-inducible factor (HIF). Although studies of VHL-defective renal carcinoma cells
suggest the existence of other VHL tumor suppressor pathways, dysregulation of the HIF transcriptional cascade has
extensive effects that make it difficult to distinguish whether, and to what extent, observed abnormalities in these
cells represent effects on pathways that are distinct from HIF. Here, we report on a genetic analysis of HIF-dependent
and -independent effects of VHL inactivation by studying gene expression patterns in Caenorhabditis elegans.We show
tight conservation of the HIF-1/VHL-1/EGL-9 hydroxylase pathway. However, persisting differential gene expression in
hif-1 versus hif-1; vhl-1 double mutant worms clearly distinguished HIF-1–independent effects of VHL-1 inactivation.
Genomic clustering, predicted functional similarities, and a common pattern of dysregulation in both vhl-1 worms and
a set of mutants (dpy-18, let-268, gon-1, mig-17, and unc-6), with different defects in extracellular matrix formation,
suggest that dysregulation of these genes reflects a discrete HIF-1–independent function of VHL-1 that is connected
with extracellular matrix function.
Citation: Bishop T, Lau KW, Epstein ACR, Kim SK, Jiang M, et al. (2004) Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis
elegans. PLoS Biol 2(10): e289.
Introduction
The von Hippel-Lindau (VHL) gene is a tumor suppressor
that is mutated in the majority of both hereditary and
sporadic, clear-cell renal carcinomas (Kaelin 2002). In
hereditary VHL disease affected individuals are also predis-
posed to pheochromocytomas and retinal/central nervous
system hemangioblastomas and develop multiple benign
lesions in the kidney and other organs. Despite more than a
decade of intensive investigation following identiﬁcation of
the defective gene in 1993 (Latif et al. 1993), the nature of the
VHL tumor suppressor mechanism and how it relates to the
physiological function of VHL remains unclear (Kaelin 2002).
To date, the best-understood function of VHL is as a
ubiquitin ligase that affects oxygen-dependent proteolytic
targeting of the a subunits of hypoxia-inducible factor (HIF)
(Maxwell et al. 1999; Ohh et al. 2000). Oxygen-dependent
hydroxylation of two HIF-a prolyl residues by HIF prolyl
hydroxylases (Epstein et al. 2001; Ivan et al. 2001; Jaakkola et al.
2001) promotes interaction with VHL and targets HIF-a for
degradation by the ubiquitin-proteasome pathway. In VHL-
defective cells HIF-a subunits are stabilized and HIF is
constitutively activated, resulting in the upregulation of HIF
target genes (Maxwell et al. 1999). Whether this, or other
putative VHL pathways, accounts for the tumor suppressor
action is the subject of active investigation (Kondo et al. 2002,
2003; Maranchie et al. 2002). For instance, a number of
different VHL-dependent cellular phenotypes have been
deﬁned by contrasting VHL-defective cells with transfectants
re-expressing wild-type VHL (Kaelin 2002). These have high-
lighted effects of VHL on invasiveness, branching morpho-
genesis, and matrix assembly (Ohh et al. 1998; Koochekpour et
al. 1999; Davidowitz et al. 2001; Kamada et al. 2001; Esteban-
Barragan et al. 2002). However, mechanistic links to VHL
function have not yet been deﬁned and it is unclear whether or
not these effects are secondary to dysregulation of HIF. This
has led to attempts todeﬁne the existence, orotherwise, of non-
HIF, VHL-regulated pathways by comparing patterns of gene
expression induced by VHL inactivation with those induced by
hypoxia (Wykoff et al. 2000; Zatyka et al. 2002; Y. Jiang et al.
2003). The observed patterns are not fully concordant,
suggesting that there may be non-HIF, VHL-regulated path-
ways. However, these studies leave important uncertainties
since HIF dysregulation might have secondary effects on
pathways that are not themselves responsive to hypoxia and
VHL might target hypoxia pathways other than HIF.
To address this we have used a genetic approach in
Caenorhabditis elegans. Whereas mammalian cells possess three
HIF-a isoforms that are targeted by VHL, C. elegans has a single
HIF-a homolog (HIF-1) and a single VHL homolog (VHL-1),
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simplifying the genetic approach (Epstein et al. 2001;H. Jiang et
al. 2001). Since homozygous vhl-1 and hif-1 loss-of-function
worms are viable, we created hif-1; vhl-1 worms and compared
the effects of vhl-1 inactivation on gene expression in wild-type
and HIF-1–defective backgrounds. Our results clearly demon-
strate the existence of both HIF-dependent and HIF-inde-
pendent pathways of VHL-dependent gene expression. HIF-1–
dependent effects of vhl-1 inactivationongeneexpressionwere
also produced by inactivation of the HIF prolyl hydroxylase
homolog EGL-9. In contrast, the HIF-1–independent effects of
vhl-1 inactivation were not observed in egl-9 loss-of-function
worms but were seen in a panel of mutant worms (dpy-18, let-
268, gon-1, mig-17, and unc-6) bearing defects in genes involved
in extracellular matrix function, supporting the existence of a
conserved non-HIF pathway connecting VHL with an as yet
unknown extracellular matrix function.
Results
Effect of VHL-1 Inactivation on Gene Expression in C.
elegans
As a ﬁrst step in deﬁning VHL-1–dependent pathways in C.
elegans, a whole-genome microarray was probed to compare
transcript patterns in vhl-1 versus wild-type worms (n = 1).
Table 1. Top 30 Upregulated Genes in the vhl-1 versus Wild-Type Microarray Comparison and Confirmation of Selected Genes by RNase Protection Assays
Gene Name Description Microarrays:
vhl-1/Wild-Type
RNase Protection Assays:
vhl-1/Wild-Type
Fold
Regulation Conﬁrmation
Fold
Regulation p Value
F22B5.4 — 25.3 Y 31.7 , 0.01
C32H11.9 — 8.6 N
nhr-57/T05B4.2 Member of the nuclear hormone receptor/zinc finger protein fa-
mily
8.0 Y 7.3 , 0.01
C32H11.10 — 6.4 —
C55B7.4 Member of the acyl-CoA dehydrogenase protein family 6.2 N
fmo-12/K08C7.5 Member of the flavin-binding monooxygenase family, which are
xenobiotic-metabolizing enzymes; has moderate similarity to fla-
vin-containing monooxygenase 5 (human FMO5)
5.9 Y 2.8 , 0.05
Y59A8B.19 — 5.0 —
K09E4.4 Protein with moderate similarity to alpha-N-acetylglucosamini-
dase (Sanfilippo disease IIIB, human NAGLU), which catalyzes the
stepwise degradation of heparan sulfate and is associated with
Sanfilippo syndrome type B upon mutation
4.9 N
T03F1.6 — 4.8 —
W07A12.6 G protein-coupled receptor, member of unnamed subfamily with
distant homology to SRG subfamily, no homolog found in hu-
man or Drosophila melanogaster
4.8 —
ZK896.4 — 4.6 —
egl-9/F22E12.4 Dioxygenase; regulates HIF-1 by prolyl hydroxylation 4.6 Y 1.8 , 0.01
Y43F8C.2 Neuropeptide neurotransmitter 4.5 —
F37B1.8 Protein containing glutathione S-transferase N-terminal and C-
terminal domains, has low similarity to prostaglandin D2
synthase (human PGDS), which is a prostaglandin D synthase
and glutathione S-transferase that regulates non-rapid eye move-
ment sleep
4.4 N
Y51A2A.4 — 4.3 —
K08D8.5 — 4.3 N
phy-2/F35G2.4 Prolyl 4-hydroxylase alpha subunit 4.1 Y 6.8 , 0.01
C09E8.3 — 4.1 —
Y34D9A.1 — 4.1 —
R09B5.3 — 4.1 —
F28B4.3 Protein containing two epidermal growth factor-like domains, a
von Willebrand factor type A domain, and a C-type lectin do-
main, which mediate calcium-dependent carbohydrate recogni-
tion
4.0 —
C31C9.1 — 4.0 —
T20F5.4 — 4.0 —
H14N18.4 Member of the gamma-glutamyltransferase (tentative) protein fa-
mily
3.9 N
C16C10.3 Piwi-related protein with similarity over the C-terminal region to
human and D. melanogaster PIWI proteins and C. elegans PRG-1
and PRG-2, all of which are involved in germ-line proliferation
3.9 N
F07C4.7 — 3.7
R166.5 Protein containing a protein kinase domain, has a region of
moderate similarity to MAP kinase-interacting serine-threonine ki-
nase 1 (human MKNK1), which is a kinase activated by the ERK
and p38 MAP kinase signaling pathways
3.4 —
F16B4.7 — 3.3 —
cah-4/R01E6.3 Protein containing three eukaryotic-type carbonic anhydrase do-
mains, which catalyze reversible hydration of carbon dioxide; has
low similarity to carbonic anhydrase 2 (human CA2), which hy-
drates carbon dioxide to form a bicarbonate ion and a proton
2.8 Y 2.3 , 0.01
C04F6.3 Member of the glycosyl hydrolase 18 family, contains two chitin
binding peritrophin-A domains, has moderate similarity to chiti-
nase 1 (chitotriosidase, human CHIT1), which catalyzes the hydro-
lysis of chitin and is associated with Gaucher disease
2.8 N
Confirmation of selected genes: Y, reproducible upregulation of gene in vhl-1/wild-type worms as confirmed by RNase protection assays; N, no reproducible upregulation of gene as tested by RNase
protection assays; —, not determined. Gene name refers to the three-letter gene name where available and open reading frame name (WormBase); details of name changes and primers in arrays are from
http://worm-chip.stanford.edu/pcr.all_primers.plus_gels.4–10-02.txt. Description is the predicted protein, annotated by Proteome/Incyte; —, protein of unknown function. Microarrays and RNase
protection assays were performed using worms cultured under normoxic conditions.
DOI: 10.1371/journal.pbio.0020289.t001
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From this array a set of genes (selected for amplitude of
differential expression, signal intensity, quality of array
signal, and putative function) was assayed quantitatively by
ribonuclease (RNase) protection (Table 1). Of the 14 genes
analyzed, six (F22B5.4, unknown function; nhr-57, predicted
nuclear hormone receptor; fmo-12, predicted ﬂavin mono-
oxygenase; egl-9,HIF-1 prolyl hydroxylase [Epstein et al. 2001];
phy-2, procollagen prolyl 4-hydroxylase a subunit [Friedman
et al. 2000]; and cah-4, predicted carbonic anhydrase) were
strikingly downregulated by VHL-1 (Figure 1A; Table 2,
column B). Further analysis in synchronized worm popula-
tions indicated that the VHL-1–dependent effects were
observed in all stages (Figure 1B and unpublished data).
Analysis of the EGL-9/HIF-1 Pathway
To determine the extent to which disruption of the
conserved EGL-9/HIF-1 pathway mediates these effects we
studied wild-type, hif-1, vhl-1, and egl-9 single mutant worms
and hif-1; vhl-1 and egl-9; hif-1 double mutant worms. Apart
from the mild phenotype of the vhl-1 worms (slightly
uncoordinated, slow growth, and reduced brood size) and
the egg-laying defective phenotype of egl-9, none of the worm
strains showed obvious phenotypic abnormalities. Interest-
ingly, hif-1 corrected the phenotype of egl-9.
The ﬁndings indicate that all six genes are strongly
regulated by the EGL-9/HIF-1 pathway (Figure 1A; Table 2).
All six genes were inducible by hypoxia in wild-type worms
Figure 1. HIF-1–Dependent Effects of VHL-1 Inactivation
Representative RNase protection assays of genes that were differentially expressed in the vhl-1 versus wild-type microarray in (A) mixed-stage
and (B) synchronized populations of worm. All genes are regulated by the VHL-1/HIF-1/EGL-9 pathway.
(C) Regulation of nhr-57mRNA in egl-9; vhl-1 worms and by egl-9 RNAi and DIP in vhl-1 worms. For RNAi experiments controls were L4440 vector
alone () and C17G10.1, an irrelevant putative dioxygenase.
F21C3.5 is a constitutively expressed gene used to control for RNA integrity. RNase protection assays were performed using worms cultured
under normoxic conditions, unless otherwise indicated.
DOI: 10.1371/journal.pbio.0020289.g001
Table 2. Differential Expression of VHL-1–Regulated Genes in Mutants Affecting the HIF-1/VHL-1/EGL-9 Pathway
Gene Name A B C D E F G H I
vhl-1 N/
wild-type
N Array
vhl-1 N/
wild-type
N
egl-9 N/
wild-type N
wild-type H/
wild-type N
hif-1; vhl-1
N/hif-1N
egl-9; hif-1
N/hif-1N
hif-1
H/hif-1 N
hif-1; vhl-1
H/hif-1;
vhl-1 N
egl-9; hif-1
H/egl-9;
hif-1 N
F22B5.4 25.3 (1) 31.7 (3) * 87.4 (3) * 27.5 (3) * 0.7 (1) 0.7 (1) 0.6 (5) 1.5 (1) 1.3 (1)
nhr-57 8.0 (1) 7.3 (3) * 108.2 (3) * 5.0 (3) * 1.0 (1) 0.4 (1) 4.7 (3) * 12.5 (1) 15.5 (1)
fmo-12 5.9 (1) 2.8 (4) * 4.6 (4) * 3.7 (4) * 1.6 (3) 1.9 (3) 1.2 (4) 1.0 (3) 0.8 (3)
egl-9 4.6 (1) 1.8 (3) * 5.1 (3) * 3.3 (3) * 1.2 (1) 1.3 (1) 1.5 (3) * 2.7 (1) 1.9 (1)
phy-2 4.1 (1) 6.8 (3) * 10.3 (3) * 8.5 (3) * 1.2 (1) 1.2 (1) 0.6 (5) 0.7 (1) 0.5 (1)
cah-4 2.8 (1) 2.3 (3) * 2.0 (3) * 4.1 (3) * 1.1 (1) 1.6 (1) 1.6 (3) 6.2 (1) 2.5 (1)
Column A, data from the microarray comparison of vhl-1 versus wild-type worms. Columns B to I, data from RNase protection assays. The figures represent the (fold) differences in expression averaged for
the indicated number (n) of independent comparisons. Statistical analysis of differential expression was performed where n  3; *, p, 0.05. Statistical analysis was performed for differences between vhl-
1 versus wild-type (column B) and egl-9 versus wild-type (column C); , p , 0.05. N, normoxia; H, hypoxia (0.1% oxygen).
DOI: 10.1371/journal.pbio.0020289.t002
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(Table 2, column D) and strikingly upregulated in egl-9 worms
(Table 2, column C). hif-1 inactivation abrogated the upregu-
lation by the egl-9 mutation (Table 2, columns C and F) and
strikingly reduced induction by hypoxia (Table 2, columns D
and G). Computational analysis revealed that ﬁve (F22B5.4,
nhr-57, fmo-12, egl-9, and cah-4) of the six genes contained a
potential HIF-1 binding core motif (RCGTG) within an
arbitrarily deﬁned region (1,000 to þ250 nucleotides) that
was conserved in Caenorhabditis briggsae (Table 3), suggesting
that these genes are direct HIF-1 transcriptional targets.
Though the six genes all conformed to the above patterns
to demonstrate regulation by the EGL-9/HIF-1 pathway
(Figure 1A; Table 2), there were differences. First, for some
genes (F22B5.4, nhr-57, and fmo-12) expression in normoxia
was entirely dependent on HIF-1, whereas other genes
retained substantial normoxic expression in hif-1 worms
(Figure 1A). Second, three genes (nhr-57, egl-9, and cah-4)
showed modest upregulation, and one gene (phy-2) showed
modest downregulation, by hypoxia that was independent of
HIF-1, VHL-1, and EGL-9 (Table 2, columns G–I). Finally, for
certain genes, upregulation was clearly greater in egl-9 than
vhl-1 worms, results being particularly striking for nhr-57
(Table 2, columns C and B). To pursue this, we created egl-9;
vhl-1 double mutants and also exposed vhl-1 worms to egl-9
RNAi. Both procedures increased nhr-57 expression, indicat-
ing that EGL-9 has non–VHL-1–mediated effects on this
pathway (Figure 1C). Interestingly, the effects of genetic
inactivation of egl-9 in the vhl-1 background were not
mimicked by the dioxygenase inhibitor 2,29-dipyridyl (DIP),
suggesting that the VHL-1–independent repressive effects on
nhr-57 may be nonenzymatic.
Evidence for a VHL-1–Dependent, HIF-1–Independent
Pathway
To address directly whether HIF-1–independent, VHL-1–
mediated pathways exist, we performed further microarray
comparisons of RNA from hif-1; vhl-1 and hif-1 worms (n = 3).
Fewer genes showed differential expression than in the vhl-1
versus wild-type array; however, persisting differential ex-
pression did suggest the existence of VHL-1 pathways that are
independent of HIF-1 (Table 4). To test this, a number of
genes were selected for further validation by RNase protec-
tion assay on the basis of amplitude of differential expression,
p value, signal intensity, and quality of array signal. Of the 25
genes analyzed by RNase protection assay (Table 4), six
(C01B4.7, F56A4.10, C01B4.9, and C01B4.8, all predicted
transmembrane proteins belonging to the major facilitator
superfamily [InterPro: IPR007114 and IPR005828]; F56A4.2, a
predicted C-type lectin [InterPro: IPR001304]; and C01B4.6, a
predicted aldose epimerase [InterPro: IPR008183]) showed
clear downregulation by VHL-1 in a HIF-1–independent
manner (Figure 2A; Table 5, column C). These effects were
observed across essentially all developmental stages of the
worm (Figure 2B). Computational analysis revealed that only
one (C01B4.8) of the ﬁve HIF-1–independent, VHL-1–
dependent genes tested (C01B4.7, F56A4.10, C01B4.9,
C01B4.8, and C01B4.6; no single ortholog of F56A4.2 could
be identiﬁed in C. briggsae) contained a potential HIF-1
binding site (HBS) within an arbitrarily deﬁned region that
was conserved in C. briggsae (see Table 3). This contrasts with
the HIF-1–dependent, VHL-1–dependent genes validated by
RNase protection assay (see Figure 1A), for which potential
HBSs could be deﬁned for ﬁve of the six genes tested (see
Table 3).
Interestingly, all six genes validated by RNase protection
assay to be negatively regulated by VHL-1 in a HIF-1–
independent manner localize within 45 kb on Chromosome V
(although they were not situated in physical proximity on the
array). We applied single-linkage clustering (nearest-neighbor
method) (Sneath 1957; Dillon and Goldstein 1984; Roy et al.
2002) to identify spatial clusters of genes considered to be
negatively regulated by VHL-1 in a HIF-1–independent
Table 3. Evolutionarily Conserved HBS Consensus Sequences
Gene Name Organism Relative Position Orientation Sequence
F22B5.4 C. elegans 470/482 Antisense GACTACGTGCCGA
C. briggsae 478/490 Antisense GACTACGTGCCGA
nhr-57 C. elegans 271/259 Sense GCGTACGTGATTA
C. briggsae 274/262 Sense GCGTACGTGATTA
C. elegans 109/121 Antisense GTCTACGTGAGAA
C. briggsae 93/105 Antisense GCCTACGTGAGAA
fmo-12 C. elegans 203/191 Palindrome CAACACGTGTTCC
C. briggsae 253/241 Palindrome CCACACGTGTTCC
egl-9 C. elegans 86/98 Antisense AACGACGTGGCAC
C. briggsae 114/126 Antisense AACGACGTGACAG
C. elegans 69/81 Antisense GTGAACGTGATAA
C. briggsae 97/109 Antisense GTGAACGTGACAA
cah-4 (a) C. elegans þ245/þ233 Palindrome GCACACGTGTTGT
C. briggsae þ236/þ224 Antisense GCAGACGTGTTGT
C01B4.8 C. elegans 300/288 Sense GATGACGTGACTT
C. briggsae 357/345 Sense GATGACGTGACTC
Consensus motif RCGTG
The sequence column shows alignments between C. elegans and C. briggsae that conserve a match (bold type) to the mammalian HBS consensus motif, RCGTG, where R = A or G. Matches were found on
both the sense and antisense strands; matches that are perfect palindromes (CACGTG) can be considered equally good matches to both the sense and antisense strand. The antisense matches are
oriented to demonstrate alignment with the consensus motif. The positions of the aligned sequences are shown relative to the translation initiation site. The gene cah-4 has two alternate first exons
(denoted ‘‘a’’ and ‘‘b’’ in WormBase); both were evaluated. In addition to the genes shown, C01B4.7, F56A4.10, C01B4.9, and C01B4.6 were screened for conserved RCGTG motifs, but none was found.
DOI: 10.1371/journal.pbio.0020289.t003
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Table 4. Upregulated Genes in the hif-1; vhl-1 versus hif-1 Microarray Comparisons and Confirmation of Selected Genes by RNase Protection Assays
Gene Name Description Microarrays:
hif-1;vhl-1/hif-1
RNase Protection Assays:
hif-1;vhl-1/hif-1
Fold
Regulation p Value Conﬁrmation
Fold
Regulation p Value
F56A4.9/Y19D10A.7 — 16.6 , 0.01 *
F56A4.3/Y45G12C.2 Member of glutathione S-transferase protein family, has
similarity to human glutathione S-transferases
7.7 , 0.05 N
F17E9.11 Member of an uncharacterized protein family with simi-
larity to Entemeba histolytica lysozymes
6.6 0.06 N
F56F3.4 Member of the ubiquitin family, contains an AN1-like
zinc finger domain
5.2 0.08 N
Y19D10A.4/C01B4.7 Member of the sugar (and other) transporter family, has
low similarity to solute carrier family 17 member 1
(mouse Slc17a1), which is involved in sodium-depen-
dent phosphate transport and hepatic and renal anion
drug transport
5.1 , 0.05 Y 4.5 , 0.01
Y39C12A.4 — 4.7 , 0.05 —
F56A4.10/Y19D10A.8 — 4.0 , 0.01 Y 3.7 , 0.01
F35E8.8 Protein containing a glutathione S-transferase N-term-
inal domain, has low similarity to prostaglandin D2
synthase (hematopoietic) (human PGDS), which is a
prostaglandin D synthase and glutathione S-transferase
that regulates non-rapid eye movement sleep
3.8 , 0.05 N
Y19D10A.12/C01B4.9 Protein with a region of low similarity to a region of
monocarboxylate cotransporter 2, (rat Slc16a7), which
mediates the transport of lactate and pyruvate across
plasma membranes
3.6 , 0.05 Y 3.2 , 0.01
Y11D7A.11 Protein containing two collagen triple helix repeats,
which are found in some extracellular proteins, and a
nematode cuticle collagen N-terminal domain, has low
similarity to C. elegans MEC-5, which is a collagen
3.6 0.05 N
F36D3.9 Protein with high similarity to cathepsin B (human
CTSB), which is a cysteine (thiol) protease that degrades
cartilage matrix proteins and facilitates tumor invasion,
member of the papain family of cysteine proteases
3.6 0.07 N
F22D6.10 Protein containing two collagen triple helix repeats and
one nematode cuticle collagen N-terminal domain, has
moderate similarity to C. elegans ROL-6, which is a pu-
tative collagen that functions in morphogenesis of the
epithelium and cuticle synthesis
3.5 0.07 N
Y39G8B.8 — 3.4 , 0.01 N
C01B4.8/Y19D10A.5 Member of the sugar (and other) transporter family, has
low similarity to solute carrier family 17 member 1
(mouse Slc17a1), which is involved in sodium-depen-
dent phosphate transport and hepatic and renal anion
drug transport
3.4 , 0.05 Y 2.9 , 0.01
F56A4.7/Y45G12C.12 — 3.3 , 0.05 —
Y39C12A.5 — 3.3 , 0.01 NS
F38A5.10 — 3.2 , 0.05 —
F56A4.2/Y19D10A.9 — 3.1 , 0.05 Y 3.3 , 0.01
T11F9.6 Putative zinc metalloprotease 3.0 0.06 N
T05A10.3 Member of the transthyretin-like family 2.9 0.08 N
F39F10.1 — 2.8 , 0.05 —
F44G3.10 — 2.8 , 0.05 —
C01B4.6/Y19D10A.4 Member of the aldose 1-epimerase family, which inter-
convert aldoses between their alpha- and beta-forms;
has low similarity to a region of Saccharomyces cerevi-
siae Gal10p, which is an UDP-glucose 4-epimerase that
catalyzes a step in galactose metabolism
2.7 , 0.01 Y 2.7 , 0.01
T06E4.8 — 2.6 , 0.05 N
hlh-8/C02B8.4 Helix-loop-helix DNA-binding domain family member;
involved in the development and differentiation of sev-
eral different mesoderm-derived cells
2.5 0.06 N
T05B4.3 — 2.5 , 0.05 —
C46H11.7 — 2.4 , 0.05 —
T06E4.9 — 2.4 , 0.05 —
F58B3.2 Member of an uncharacterized protein family with simi-
larity to E. histolytica lysozymes
2.4 , 0.05 N
W02A2.3 — 2.2 0.05 N
ZK1307.2 — 2.2 , 0.05 —
ZC196.5 — 2.2 , 0.05 —
M04C3.1 Protein containing an SNF2-related N-terminal domain 2.2 , 0.05 —
Y43F8B.14 — 2.2 , 0.05 —
Y40C7B.3 — 2.2 , 0.01 —
C39H7.4 — 2.2 0.07 —
Y37E11AR.6 Protein with weak similarity to C. elegans efn-4 (protein
with some similarity to class A and B vertebrate
ephrins)
2.1 , 0.01 —
T19A6.3 — 2.1 0.09 —
T02E9.2 — 2.1 0.05 —
F23A7.5 Member of the polypeptide chain release factor protein
family
2.1 , 0.05 —
Y2H9A.4 — 2.1 , 0.05 —
Y53F4B.2 — 2.1 , 0.05 —
C24A8.4 Member of the rhodopsin family of G protein-coupled
receptors (GPCR), has a region of high similarity to
yeast Sps1Ste20-related kinase 3 (mouse Stk4), which is
a protein kinase that may function in apoptosis
2.1 , 0.05 —
Y45G12C.9/C13B7.4 — 2.1 , 0.01 —
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manner from the microarray data (Table 4) and random
sampling to evaluate the signiﬁcance of such clusters. Using a
clustering threshold of 96,985 bp (see Materials and Methods),
one cluster of ten genes and four clusters of two genes were
identiﬁed (Figure 3A). On 100,000 simulated datasets of 57
randomly selected genes (equal number to that of VHL-1–
dependent, HIF-1–independent genes; Table 4), the fre-
quency of observed cluster sizes was as follows: one gene,
5,043,442; two genes, 298,425; three genes, 18,198; four genes,
1,190; ﬁve genes, 66; six genes, 4. No clusters of more than six
genes were observed. Therefore, the cluster of ten VHL-1–
regulated (HIF-1–independent) genes, which extends over
110 kb to include F56A4.9, Y45G12C.9, Y45G12C.12, and
Y45G12C.2 in addition to the six genes validated by RNase
protection assays, can be considered statistically signiﬁcant to
p  105 (Figure 3B). Recent C. elegans genomic assemblies
(for example, WS120) have shown that the entire 110-kb
region containing the coregulated gene cluster is arranged in
tandem with a second nearly identical segmental duplication
of the locus (.99.9% identical in alignment). At this level of
identity, our microarray and RNase protection analyses
cannot discriminate between the two copies of each gene,
so for all of our analyses we have only used the names of the
distal copy and genes from the proximal copy were excluded
from computational analyses.
Extracellular Matrix Link to Novel VHL-1 Pathway
Since ubiquitin ligases commonly recognize more than one
substrate, we considered whether these HIF-1–independent
genes might be regulated by prolyl hydroxylation of another
VHL-1 substrate by EGL-9. However, this was not supported
by any differential expression in egl-9; hif-1 versus hif-1 worms
(Figure 4A; Table 5, column E). Nevertheless, two genes,
C01B4.7 and C01B4.8, were upregulated in hif-1 worms by
hypoxia and the 2-oxoglutarate dioxygenase inhibitors, DIP
and dimethyloxalylglycine (DMOG) (Figure 4; Table 5,
column F), suggesting that another enzyme in this class might
be involved. The procollagen prolyl hydroxylases DPY-18,
PHY-2, and PHY-3 (Friedman et al. 2000; Riihimaa et al. 2002)
and the procollagen lysyl hydroxylase LET-268 (Norman and
Moerman 2000) were tested as potential candidates. A clear
pattern was observed. All six VHL-1–regulated, HIF-1–
independent genes were reproducibly downregulated by
DPY-18 and LET-268 but not by PHY-2 or PHY-3 (Figure
5A; Table 5, columns H–K). The strain carrying the hetero-
zygous let-268 mutation is heterozygous for unc-4, dpy-10, and
unc-52; however, the VHL-1–dependent, HIF-1–independent
genes were not differentially expressed in unc-4, dpy-10, or
unc-52 worms, indicating that the effects were due to LET-268
(unpublished data). Further experiments on dpy-18; hif-1
double mutant worms clearly indicated that the effects of
DPY-18 on this group of genes were (like the effects of VHL-
1) HIF-1 independent (Figure 5C and unpublished data).
Downregulation by DPY-18 and LET-268 is consistent with
the positive effects of hypoxia, DIP, and DMOG, since all
these stimuli inhibit DPY-18 and LET-268. However, the
involvement of a lysyl, as well as a prolyl, hydroxylase
suggests that the effects were unlikely to arise from failure of
hydroxylation of a second prolyl hydroxylation substrate
recognized by VHL-1 and were more likely to be related to a
common function of DPY-18 and LET-268, such as a
function in extracellular matrix formation. To pursue this,
we tested the effects of defects in proteins involved in other
aspects of extracellular matrix formation (either in the
cuticle or basement membrane) that are distinct from
protein hydroxylation. These experiments indicated that
the six genes were, to varying extents, upregulated in the
basement membrane-associated gon-1 (heterozygote), mig-17,
and unc-6 mutant worms but not in the cuticle-associated
dpy-11, bli-4, or sqt-3 mutant worms (Figure 5B and
unpublished data). In contrast, none of the HIF-1–depend-
ent genes was upregulated in these mutants (Figure 5B and
Table 4. Continued
Gene Name Description Microarrays:
hif-1;vhl-1/hif-1
RNase Protection Assays:
hif-1;vhl-1/hif-1
Fold
Regulation p Value Conﬁrmation
Fold
Regulation p Value
Y38C1BA.3 — 2.1 0.09 —
Y37E11C.1 Putative component of the axonal cytoskeleton re-
quired for proper axon morphology; similar to the H.
sapiens DPYS gene product
2.1 , 0.05 —
Y46G5A.26 — 2.1 , 0.05 —
F27C8.4 — 2.1 , 0.05 —
ZK180.5 Protein of unknown function, has weak similarity to hu-
man transmembrane mucin 1, MUC1
2.1 0.07 —
C45B2.2 — 2.1 0.05 —
R13A5.6 Member of the transthyretin-like family 2.1 , 0.05 —
C42D4.3 Protein containing a DB module domain 2.1 0.05 —
Y43F8C.1 YGGWamide neurotransmitter 2.1 0.05 —
Y43F4A.1 — 2.1 , 0.05 —
ZC196.4 — 2.1 0.05 —
R01E6.2 — 2.1 0.06 —
F11C1.3 Member of the CD36 family of putative scavenger re-
ceptors, has low similarity to scavenger receptor BI
(mouse Srb1), which mediates the selective uptake of
cholesterol from high- and low-density lipoproteins and
activates endothelial nitric oxide
2.1 0.07 —
Confirmation of selected genes: Y, reproducible upregulation of gene in hif-1; vhl-1/hif-1 worms as confirmed by RNase protection assays; N, no reproducible upregulation of gene as tested by RNase
protection assays; asterisk, not assayed, riboprobe could not be constructed; NS, no signal by RNase protection assay; —, not determined. Microarrays and RNase protection assays were performed using
worms cultured under normoxic conditions. C35B8.1, C46A5.3, R03D7.5, T11F9.8, and ZK1010.7 were also tested by RNase protection assay based on microarray data; these genes did not show
reproducible upregulation by RNase protection assays.
DOI: 10.1371/journal.pbio.0020289.t004
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unpublished data). GON-1 and MIG-17 encode secreted
metalloproteases and UNC-6 encodes a netrin; all are
thought to be involved in basement membrane remodeling/
cell migration during gonadal morphogenesis (Hedgecock et
al. 1990; Blelloch and Kimble 1999; Nishiwaki et al. 2000).
Conversely, DPY-11 (a thioredoxin) and BLI-4 (a serine
endoprotease) are both involved in collagen formation in the
worm cuticle (Thein et al. 2003) and SQT-3 encodes a
Table 5. Differential Expression of HIF-1–Independent, VHL-1–Regulated Genes in Mutants Affecting the HIF-1/VHL-1/EGL-9 Pathway and Procollagen Hydroxylases
A B C D E F G H I J K
Gene
Name
hif-1;
vhl-1 N/
hif-1
N Arrays
vhl-1 N/
wild-type
N Array
hif-1;
vhl-1 N/
hif-1 N
vhl-1 N/
hif-1;
vhl-1N
egl-9;
hif-1 N/
hif-1 N
hif-1 H/
hif-1 N
vhl-1 N/
wild-type
N
dpy-18 N/
wild-type
N
phy-2 N/
wild-type
N
phy-3 N/
wild-type
N
let-268 N/
wild-type
N
C01B4.7 5.1 (3) * 9.0 (1) 4.5 (11) * 1.3 (3) 1.4 (3) 4.4 (5) * 3.5 (4) * 7.4 (3) * 1.2 (3) 1.0 (3) 5.3 (3) *
F56A4.10 4.0 (3) * 2.6 (1) 3.7 (8) * 1.2 (3) 1.3 (4) 1.0 (3) 4.1 (5) * 3.9 (3) * 1.8 (3) 1.4 (3) * 3.4 (3) *
C01B4.9 3.6 (3) * 2.7 (1) 3.2 (9) * 1.0 (3) 1.3 (3) 1.3 (3) * 2.6 (5) * 2.2 (3) * 1.0 (3) 0.9 (3) 3.0 (3) *
C01B4.8 3.4 (3) * 5.0 (1) 2.9 (8) * 1.2 (3) 1.0 (3) 2.3 (3) * 3.2 (5) * 4.6 (3) * 1.6 (3) * 1.2 (3) 4.2 (3) *
F56A4.2 3.1 (3) * 1.1 (1) 3.3 (9) * 1.1 (3) 0.8 (4) 0.7 (3) 5.9 (5) * 3.5 (3) * 0.8 (3) 1.0 (3) 5.1 (3) *
C01B4.6 2.7 (3) * 1.6 (1) 2.7 (7) * 1.7 (3) 1.1 (3) 1.1 (3) 4.5 (4) * 3.8 (3) * 1.0 (3) 0.9 (3) 3.2 (3) *
Columns A and B, data from microarray comparisons; columns C to K, data from RNase protection assays. The figures represent the (fold) differences in expression averaged for the indicated number (n)
of independent comparisons. Statistical analysis of differential expression was performed where n  3; *, p , 0.05. N, normoxia; H, hypoxia (0.1% oxygen).
DOI: 10.1371/journal.pbio.0020289.t005
Figure 2. HIF-1–Independent Effects of VHL-1 Inactivation
RNase protection assays of genes that were differentially expressed in the hif-1; vhl-1 versus hif-1 microarrays in (A) mixed-stage and (B)
synchronized populations of worm. The results conﬁrm the existence of VHL-1–dependent, HIF-1–independent effects on gene expression.
DOI: 10.1371/journal.pbio.0020289.g002
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cuticular collagen. These results therefore extend the
characterization of the VHL-1–dependent, HIF-1–independ-
ent pathway and support a connection with extracellular
matrix/basement membrane function.
Discussion
By comparing the effects of vhl-1 inactivation in different
genetic backgrounds, these data clearly distinguish HIF-1–
dependent and –independent effects of VHL-1 on gene
expression. Somewhat surprisingly, all of the VHL-regulated
genes analyzed fell into one of two patterns: independent of
HIF-1 and EGL-9 and dependent on DPY-18, LET-268, GON-
1, MIG-17, and UNC-6, or the reverse, suggesting that they
reﬂect perturbation of two discrete aspects of VHL-1
function.
The HIF-1–dependent expression pattern of all six genes
chosen for detailed analysis from the vhl-1 versus wild-type
array underlines the importance of the HIF-1 pathway in
VHL-1 function. Computational analysis revealed that ﬁve of
these genes (F22B5.4, nhr-57, fmo-12, egl-9, and cah-4) have at
least one HIF-1 binding core motif (RCGTG) that is
conserved in C. briggsae within an arbitrarily deﬁned (1,000
to þ250 nucleotides) promoter region, suggesting that they
are direct HIF-1 transcriptional targets. Several genes (egl-9,
HIF prolyl hydroxylase; phy-2, procollagen prolyl 4-hydrox-
ylase a subunit; and cah-4, carbonic anhydrase) have mamma-
lian homologs that are HIF targets (Ivanov et al. 1998;
Takahashi et al. 2000; Epstein et al. 2001), emphasizing the
extent of conservation of the pathway. Others, such as ﬂavin
monooxygenase fmo-12 and the nuclear hormone receptor
nhr-57, are apparently novel HIF-1 target genes. Interestingly,
some of these HIF-1–dependent genes were partly down-
regulated by EGL-9 in a VHL-1– and iron-independent
manner, suggesting that, in addition to the HIF-1/VHL-1
pathway, EGL-9 regulates HIF-1 transcriptional activity via a
novel pathway.
Remarkably, among the candidate genes tested from the
hif-1; vhl-1 versus hif-1 screens, all six that showed reprodu-
cible (HIF-1–independent) regulation by VHL-1 were located
within 45 kb on Chromosome V. Analysis of the microarray
data revealed that there was indeed a single, highly
signiﬁcant (p , 105) chromosomal cluster of genes
negatively regulated by VHL-1 in a HIF-1–independent
manner and that in total this cluster extended over 110 kb
to include F56A4.9, Y45G12C.9, Y45G12C.12, and Y45G12C.2
in addition to the six genes validated by RNase protection
assay. The chromosomal localization of genes in C. elegans is
not random, with functionally related genes located close to
one another (Roy et al. 2002) or even organized into operons
(Blumenthal and Gleason 2003). Even though, based on the
absence of spliced leader SL2 sequences (Blumenthal et al.
2002) and the presence of inverse transcriptional orienta-
tions, the genes in this cluster do not appear to be within the
same operon, there may be a functional relevance to their
physical proximity. Four of the six genes validated by RNase
protection assay (C01B4.7, F56A4.10, C01B4.9, and C01B4.8)
encode membrane transporters of the major facilitator
Figure 3. Chromosomal Clustering of VHL-1–Dependent (HIF-1–Independent) Genes
(A) Chromosomal localization of VHL-1–dependent, HIF-1–independent genes. The positions of the genes from Table 4 are indicated by vertical
ticks along the C. elegans chromosomes (shown to scale). Where two such genes are too close to be clearly resolved, the tick is marked by an
asterisk. The single signiﬁcant spatial clustering of VHL-1–dependent, HIF-1–independent genes is indicated by a red rectangle. The histogram
under each chromosome shows the gene density (deeper bar, greater density) calculated as a sliding window of 100,000 bp moving with 10,000-bp
increments along each chromosome. Dark blue indicates total annotated gene density, and light blue indicates the density of genes from the
microarray that passed preliminary quality control.
(B) Organization of the VHL-1–regulated (HIF-1–independent) gene cluster from Chromosome V. The relative positions and sizes of gene
transcription units are shown to scale, with genes transcribed left to right above the horizontal line and right to left below the line. Names in
black indicate genes that passed all selection criteria to be considered upregulated in hif-1; vhl-1 versus hif-1 worms (see Table 4). Genes with a
mean .2.0-fold upregulation are indicated by green boxes, 1.5- to 2-fold are yellow, and ,1.5-fold are red. Genes for which no data were
obtained are shown as light grey.
DOI: 10.1371/journal.pbio.0020289.g003
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superfamily, a family of transporters involved in passive
transport of small solutes. C01B4.9 clusters phylogenetically
with monocarboxylate transporters, and C01B4.7, F56A4.10,
and C01B4.8 cluster with sodium phosphate transporters
(unpublished data). Both gene families have been subject to
rounds of gene duplication in the vertebrate and nematode
lineages. As such, it is not possible to deﬁne one-to-one
orthologous relationships for these genes between C. elegans
and Homo sapiens. Nevertheless, the genomic clustering,
predicted functional similarities, and common pattern of
perturbed expression across an extensive set of mutant
worms suggest that the upregulation of the genes in vhl-1
worms reﬂects the disturbance of a speciﬁc function of
VHL-1.
The common effects of inactivating mutations in vhl-1 and
in genes that manifest functional overlap in extracellular
matrix formation—dpy-18 and let-268 (encoding procollagen
hydroxylases) (Friedman et al. 2000; Norman and Moerman
2000), gon-1 and mig-17 (encoding secreted metalloproteases)
(Blelloch and Kimble 1999; Nishiwaki et al. 2000), and unc-6
(encoding the extracellular guidance protein, netrin) (Hedge-
cock et al. 1990)—suggest a related function for this HIF-1–
independent VHL pathway. Interestingly, VHL-defective
renal carcinoma cells demonstrate a variety of matrix-related
abnormalities, including abnormal ﬁbronectin assembly,
defective formation of ﬁbrillar adhesions, and changes in
branching morphogenesis and migration (Ohh et al. 1998;
Koochekpour et al. 1999; Davidowitz et al. 2001; Kamada et
al. 2001; Esteban-Barragan et al. 2002). These abnormalities
can be corrected by transfection of renal carcinoma cells
with wild-type vhl, indicating that they are attributable,
either directly or indirectly, to VHL loss of function.
Furthermore, immunoprecipitation studies using renal car-
cinoma cell extracts have indicated that VHL binds to
ﬁbronectin (Ohh et al. 1998). Most tumor-associated VHL
mutants, when transfected into VHL-defective renal carci-
noma cells, are defective in both complementing HIF
dysregulation and ﬁbronectin binding (Kaelin 2002). How-
ever, mutations associated with type 2C (predisposition to
pheochromocytoma only) VHL disease complement defec-
tive HIF regulation but bind ﬁbronectin with lower afﬁnity
than wild-type VHL (Hoffman et al. 2001). Though the
precise link to abnormal matrix assembly remains unclear,
this has suggested a HIF-independent function of VHL. The
present study supports the existence of a HIF-independent
pathway connected with extracellular matrix function and
suggests that this may be a highly conserved function of VHL
that is potentially amenable to genetic analysis in model
organisms.
Materials and Methods
Strains and culturing conditions. Worms were studied as mixed-
stage populations or as synchronized populations following brief
exposure to sodium hypochlorite. Exposure to hypoxia (2% or 0.1%
oxygen), DIP (200 lM), and DMOG (1 mM) was for 18 h (Epstein et al.
2001). RNA interference (RNAi) was performed by feeding worms
Escherichia coli strain HT115(DE3) expressing double-stranded (ds)
RNA on Nematode Growth Medium containing 1 mM isopropyl-b-D-
thiogalactopyranoside (ITPG) and 50 lg/ml ampicillin for 72 h.
Plasmids for ds RNA production were derivatives of the L4440 vector
and were obtained from J. Ahringer (Cambridge, United Kingdom); ds
RNA sequences are available on WormBase (http://www.wormbase.
org). Wild-type worms were Bristol strain (N2); mutant strains were
obtained from the Caenorhabditis Genetics Center (Table 6). Strains
were maintained at room temperature except for the temperature-
sensitive gon-1 worms (maintained at 18 8C). The double mutants hif-1;
vhl-1, egl-9; hif-1, and dpy-18; hif-1 were constructed using either fog-2 or
unc-51 to mark hif-1(þ); the double mutant egl-9; vhl-1 was constructed
using unc-42 to mark egl-9(þ); PCR was used to conﬁrm homozygosity.
Microarray screening. Microarray comparisons of wild-type versus
vhl-1 worms and hif-1 versus hif-1; vhl-1 worms were performed on
independent samples of RNA (n = 1 and 3, respectively), using near
full-genome C. elegans DNA microarrays (M. Jiang et al. 2001). Total
RNA was extracted from mixed-stage populations of worm cultured
Figure 4. Responses of VHL-1–Dependent, HIF-1–Independent Genes to
egl-9 Inactivation, Hypoxia, and 2-Oxoglutarate Dioxygenase Inhibitors
RNase protection assays showing regulation of VHL-1–dependent,
HIF-1–independent genes by (A) EGL-9 and hypoxia and (B)
pharmacological inhibitors of 2-oxoglutarate dioxygenases: DIP and
DMOG. None of the genes is regulated by EGL-9, but two genes
(C01B4.7 and C01B4.8) show modest induction by hypoxia, DIP, and
DMOG.
DOI: 10.1371/journal.pbio.0020289.g004
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under normoxic conditions using Tri-reagent (Sigma, Poole, Dorset,
United Kingdom) and mRNA puriﬁed using oligo-dT beads (Qiagen,
Crawley, West Sussex, United Kingdom). cDNA synthesis and micro-
array hybridization and scanning were performed as described
previously (M. Jiang et al. 2001). Cy5-dUTP was used to label cDNA
fromwild-type and hif-1 worms and Cy3-dUTP was used to label cDNA
from vhl-1 and hif-1; vhl-1 worms. The arrays were computer
normalized by the default procedure in the Stanford Microarray
Database (SMD); primary array data are available on the SMD (http://
genome-www.stanford.edu/microarray) and are also shown in Tables
S1 through S4. Fold change was calculated as the ratio of the means of
Cy3-dUTP intensity to normalized Cy5-dUTP intensity (normalized to
correct for signal differences between Cy3-dUTP and Cy5-dUTP
intensities across the whole array) with median background intensities
subtracted from both signal intensities to correct for the background
(see SMD). Genes with background-corrected signal intensities below
zero or with array spots that were ﬂagged in the SMD as being
unreliable were discarded as a preliminary quality control. For the hif-
1 versus hif-1; vhl-1 microarray comparisons (n = 3) the log2 fold
change was calculated as the mean of the three log2 transformed fold
changes. To test for signiﬁcant upregulation, the mean log2 fold
change was compared with zero using a Student’s t test. The genes
were ranked by amplitude of fold upregulation and a subset of genes
was selected for potential validation by RNase protection assays (see
Tables 1 and 4) based on the following criteria: (a) t test, p , 0.10 (for
the hif-1 versus hif-1; vhl-1 microarray comparisons, n = 3); (b) mean
Cy3-dUTP and Cy5-dUTP background-corrected signal intensities
exceeding 300 and 100 U, respectively (lower intensities than these
were difﬁcult to detect by RNase protection assay); and (c) high spot
quality as judged by manual inspection. For the hif-1 versus hif-1; vhl-1
microarray comparisons (n = 3), genes (which had been ﬁltered as
described above) were considered to be differentially expressed if the
mean fold change was greater than 2.0 (see Table 4).
RNase protection assays. Assays were performed on total RNA
from mixed-stage populations of worm cultured under normoxic
conditions, unless otherwise indicated. Details of riboprobe tem-
plates are provided in Table 7; details of genes tested are shown in
Tables 1 and 4. Quantiﬁcation was performed using a phosphor-
imager (Molecular Dynamics, Sunnyvale, California, United States)
and related to an internal control assay for the constitutively
Figure 5. Sensitivity of VHL-1–Regulated Genes to Defects in Extracellular Matrix-Associated Proteins
RNase protection assays showing altered expression of VHL-1–regulated genes that are HIF-1 independent (upper six panels) and HIF-1
dependent (F22B5.4) in worms bearing mutations affecting (A) procollagen prolyl and lysyl hydroxylases and (B) other extracellular matrix-
associated proteins. A common pattern of upregulation is observed in hif-1; vhl-1, vhl-1, dpy-18, let-268, gon-1, mig-17, and unc-6 worms but not
other mutants. This contrasts with the HIF-1–dependent gene F22B5.4, which is upregulated in vhl-1 worms but none of the other mutants.
(C) RNase protection assay for C01B4.9 illustrating DPY-18–mediated changes in expression that are independent of HIF-1.
DOI: 10.1371/journal.pbio.0020289.g005
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expressed F21C3.5 (protein with similarity to mouse prefoldin
subunit 6). Where n  3, the log2 fold change was calculated from
the mean of the log2 transformed fold changes and statistical
signiﬁcance was calculated by comparing the mean log2 fold change
with zero using a Student’s t test.
Computational analyses. (1) Identiﬁcation of potential HBSs (see
Table 3). Orthologs of C. elegans genes were identiﬁed in the C. briggsae
genome assembly (cb25) as reciprocal best matches by BLASTN,
initiated with the C. elegans gene coding sequence (a single ortholog of
F56A4.2 could not be deﬁned). Translation initiation sites (well-
annotated surrogates for transcriptional start sites; none of these
genes are annotated as having spliced 59 UTRs) were inferred in both
C. briggsae and C. elegans through alignment with the C. elegans coding
sequence (WormBase, WS117). Sequences encompassing the 1,000
nucleotides upstream to 250 nucleotides downstream of the trans-
lation start sites for orthologous genes were aligned using DNA Block
Aligner (Jareborg et al. 1999) with the following options: gap = 0.001
and blockopen = 0.005. Sequence alignments were searched with the
HBS motif RCGTG (Camenisch et al. 2001), identifying cases where
HBS-like motifs were conserved between both C. elegans and C. briggsae.
(2) Single-linkage analysis to determine spatial clusters of VHL-1–
dependent, HIF-1–independent genes (see Figure 3). A maximum
distance for the linking of two clusters was determined by ranking the
distance between 10,000 randomly selected pairs of genes from the
same chromosome (but sampled over all six nuclear chromosomes)
and selecting as a threshold the ﬁrst percentile of the distribution,
96,985 bp. Intergene distances were calculated from the closest point
between the annotated coding sequence of each gene; genes on
separate chromosomes were considered to have an inﬁnite intergene
distance. Simulations were performed using genes selected at random
from genes that were represented on the microarray and that passed
preliminary quality control criteria. All genomic coordinates were
based on genomic assembly WS120 and the associated WormBase
annotation of genes obtained from the University of California, Santa
Cruz Genome Browser (http://genome.ucsc.edu/). The software used
for simulations and clustering was implemented in Perl and is
available on request.
Supporting Information
Primary microarray data can be viewed at http://genome-www.
stanford.edu/microarray.
Table S1. vhl-1 versus Wild-Type Microarray Comparison
Primary microarray data for the vhl-1 (green, channel 1) versus wild-
type (red, channel 2) comparison.
Found at DOI: 10.1371/journal.pbio.0020289.st001 (6.5 MB XLS).
Table S2. hif-1; vhl-1 versus hif-1 Microarray Comparisons I
Primary microarray data for the three independent hif-1; vhl-1 (green,
channel 1) versus hif-1 (red, channel 2) microarray comparisons.
Continued in Tables S3 and S4.
Found at DOI: 10.1371/journal.pbio.0020289.st002 (6.6 MB XLS).
Table S3. hif-1; vhl-1 versus hif-1 Microarray Comparisons II
Continuation of Table S2.
Found at DOI: 10.1371/journal.pbio.0020289.st003 (6.6 MB XLS).
Table S4. hif-1; vhl-1 versus hif-1 Microarray Comparisons III
Continuation of Tables S2 and S3.
Found at DOI: 10.1371/journal.pbio.0020289.st004 (6.6 MB XLS).
Accession Numbers
Primary array data have been deposited in ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/) under accession number E-SMDB-23.
The H. sapiens VHL gene discussed in this paper can be found in
Online Mendelian Inheritance in Man (OMIM) under accession
number 608537 (http://www.ncbi.nlm.nih.gov:80/entrez/dispomim.
cgi?id=608537).
The C. elegans genes discussed in this paper (bli-4, C01B4.6, C01B4.7,
C01B4.8, C01B4.9, cah-4, dpy-10, dpy-11, dpy-18, egl-9, F21C3.5, F22B5.4,
F56A4.2, F56A4.9, F56A4.10, fmo-12, fog-2, gon-1, hif-1, let-268, mig-17,
nhr-57, phy-2, phy-3, sqt-3, unc-4, unc-6, unc-42, unc-51, unc-52, vhl-1,
Y45G12C.2, Y45G12C.9, and Y45G12C.12) can be found in the
WormBase database by including the name of the gene at the end
of the URL (e.g., for bli-4, http://wormbase.org/db/gene/gene?name
=bli-4).
Table 7. Sequence and Length of Riboprobes
Gene Name 59 End
of mRNA
39 End
of mRNA
Protected
Length (bp)
C01B4.6 265 440 175
C01B4.7 123 319 196
C01B4.8 1139 1314 175
C01B4.9 35 200 165
C04F6.3 16 181 165
C16C10.3 112 291 179
C32H11.9 649 839 190
C35B8.1 118 292 174
C46A5.3 320 472 152
C55B7.4 517 690 173
cah-4 328 540 212
egl-9a 172 358 186
F17E9.11 399 576 177
F21C3.5 46 160 114
F22B5.4 195 441 246
F22D6.10 726 886 160
F35E8.8 132 281 149
F36D3.9 711 871 160
F37B1.8 137 306 169
F56A4.2 184 383 199
F56A4.10 75 270 195
F56F3.4 282 462 180
F58B3.2 187 363 176
fmo-12 173 320 147
H14N18.4 193 374 181
hlh-8 85 280 195
K08D8.5 297 469 172
K09E4.4 537 715 178
nhr-57 359 526 167
phy-2 1140 1310 170
R03D7.5 285 484 199
T05A10.3 135 321 186
T06E4.8 50 199 149
T11F9.6 147 338 191
T11F9.8 303 452 149
W02A2.3 266 443 177
Y11D7A.11 65 242 177
Y39G8B.8 104 273 169
Y45G12C.2 25 205 180
ZK1010.7 152 349 197
a Note that the protected region of the egl-9 transcript does not overlap the sa307 deletion in the
JT307 egl-9 strain.
DOI: 10.1371/journal.pbio.0020289.t008
Table 6. C. elegans Strains and Alleles
Gene Name Strain Genotype
bli-4 CB937 bli-4(e937) I
dpy-10 CB128 dpy-10(e128) II
dpy-11 CB224 dpy-11(e224) V
dpy-18 CB364 dpy-18(e364) III
dpy-18; hif-1 CB6347 dpy-18(e364) III; hif-1(ia4) V
egl-9 JT307 egl-9(sa307) V
egl-9; hif-1 CB6088 egl-9(sa307) V; hif-1(ia4) V
egl-9; vhl-1 CB6116 egl-9(sa307) V; vhl-1(ok161) X
fog-2 CB4108 fog-2(q71) V
gon-1 CB4504 gon-1(e1254)/eDf18 IVa
hif-1 ZG31 hif-1(ia4) V
hif-1; vhl-1 CB6090 hif-1(ia4) V; vhl-1(ok161) X
let-268 DM3414 unc-4(e120) let-268(ra414)/mnC1
dpy-10(e128) unc-52(e444) II
mig-17 NF8 mig-17(k113) V
phy-2 JK2757 phy-2(ok177) IV
phy-3 TP7 phy-3(ok199) V
sqt-3 CB6273 sqt-3(e2906) V
unc-4 CB120 unc-4(e120) II
unc-6 CB78 unc-6(e78) X
unc-42 CB270 unc-42(e270) V
unc-51 CB369 unc-51(e369) V
unc-52 CB444 unc-52(e444) II
vhl-1 CB5602 vhl-1(ok161) X
a Note that eDf18 carries a weak gon-1 mutation that renders the CB4504 strain temperature
sensitive for the Gon phenotype.
DOI: 10.1371/journal.pbio.0020289.t007
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